AT&S Plant in Korea is Shaping the Future of Medical Technology

Reading time ( words)

To supply the medical sector with the most modern technology in the future, AT&S has implemented a comprehensive technology upgrade at the Ansan site in Korea, with which the production technologies in the plant have been raised to a new level. “After this upgrade, around 8,000 square meters of additional production space will be available, most of which will be used for the manufacture of interconnection solutions for medical technology applications. At the same time, our production equipment was also brought up to date”, explains Christian Fleck, COO of the Automotive, Industrial and Medical business unit at AT&S.

A technological revolution is taking place in medical technology. Hearing aids, insulin pumps, and implants are already important tools for doctors today. Future applications – for example, artificial hearts, implants for specific pain suppression, or new generations of arm or leg prostheses that optimally support the natural sequence of movements, will further increase the demands on technology in medicine. Just like in other high-tech industries, products are becoming increasingly complex and multi-layered: a diagnostic device that contains two sensor functions today will need five tomorrow. The technology is becoming increasingly powerful but still has to find space in the smallest of spaces and process an increasing amount of data. This trend will increase further through new technological approaches. In diagnostics, for example, artificial intelligence will increasingly be used for data evaluation in the future, which requires the integration of new, specialized components. Circuit boards, substrates, and interconnection solutions from AT&S create the necessary platform for such highly integrated, miniaturized electronic systems.

With the newly installed systems, such as multilayer flex presses, machines for e-copper coating, and highly innovative UV lasers, production capacities will be increased by more than a quarter. On the other hand, the new infrastructure makes a significant contribution to more efficient and resource-saving circuit board production, for example in the area of​​water treatment.

“The medical technology sector is an important part of the AT&S strategy and an exciting business area that we are constantly developing,” says AT&S CEO Andreas Gerstenmayer. “With our interconnection solutions, we are among the world market leaders in this segment and are already thinking intensively with our partners about solutions with which diagnostics and therapy can be revolutionized in a few years.”

The AT&S plant in Ansan specializes in the production of high-tech printed circuit boards for a wide variety of medical areas. For example, interconnection solutions for hearing aids with special sensors for targeted noise suppression in certain situations or circuit boards for cardiac catheters that enable 3D interior images of the human heart are produced. Some manufacturers also rely on AT&S technology for smart drug pumps that can automatically dispense controlled quantities of a substance when required.



Suggested Items

Catching Up With RBP Chemical and Schlötter

01/20/2022 | Dan Beaulieu, D.B. Management Group
It’s always great to see two very good companies form a mutually beneficial alliance. I was lucky enough to watch this particular strategic partnership come to fruition this year between RBP Chemical and Schlötter. I wanted to talk to both companies, so I sat down with Matthias Hampel, global executive representative-PCB and electronics at Schlötter, and Ernest Litynski, president of RBP Chemical Technology, to get the inside story.

Technology and Development Prospects for the European Marketplace

01/18/2022 | Nolan Johnson, I-Connect007
Nolan Johnson speaks with Tarja Rapala-Virtanen technical director of the EIPC who breaks down the current state of the European market and which technologies and market segments are seeing growth.

A Tour of the New Isola Factory: Investing in North America

12/23/2021 | Barry Matties, I-Connect007
Barry Matties recently toured Isola’s new 118,000-square-foot low-volume, high-mix manufacturing facility in Chandler, Arizona. The facility’s construction began in 2020 and, like many building projects, was delayed because of the COVID-19 pandemic. Building a new factory during the pandemic was certainly a challenge but the team persevered and the new greenfield facility is now operating to meet the needs of the North American market. During the tour, Barry met with Travis Kelly, Ed Kelley, Sean Mirshafiei, Jenny Inocencio, and Walt Niziolek. They covered a range of topics, including lab operations, hiring, the supply chain, R&D, and the concept of the new facility. The factory was designed to extensively utilize automation to improve efficiencies and, as Travis Kelly stated, “to de-risk the labor shortage issue.”

Copyright © 2022 I-Connect007. All rights reserved.